A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity
- Supplementary File 1:
PDF-Document (PDF, 5780 KiB)
Alcântara, L.M.; Ferreira, T.C.S.; Fontana, V.; Chatelain, E.; Moraes, C.B.; Freitas-Junior, L.H. A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity. Molecules 2020, 25, 2551. https://doi.org/10.3390/molecules25112551
Alcântara LM, Ferreira TCS, Fontana V, Chatelain E, Moraes CB, Freitas-Junior LH. A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity. Molecules. 2020; 25(11):2551. https://doi.org/10.3390/molecules25112551
Chicago/Turabian StyleAlcântara, Laura M., Thalita C. S. Ferreira, Vanessa Fontana, Eric Chatelain, Carolina B. Moraes, and Lucio H. Freitas-Junior. 2020. "A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity" Molecules 25, no. 11: 2551. https://doi.org/10.3390/molecules25112551